What is Nigam H. Shah’s BrightSpring (BTSG) share ownership after this RSU award?

After the reported transaction, Nigam H. Shah directly holds 4,013 shares of BrightSpring common stock. This figure reflects his position following the RSU-related acquisition described in the Form 4 and shows his current direct equity stake in the company.

BrightSpring (BTSG) director Nigam Shah granted 4,013 RSUs in 2026

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Shah Nigam H. reported acquisition or exercise transactions in this Form 4 filing.

BrightSpring Health Services director Nigam H. Shah received an equity award in the form of restricted stock units. On June 11, 2026, he was granted 4,013 RSUs, each representing a right to receive one share of common stock upon settlement at no cash cost per unit.

The RSUs fully vest on the earlier of June 11, 2027 or the day before BrightSpring’s 2027 annual meeting of stockholders. Following this grant, Shah holds 4,013 shares of BrightSpring common stock directly, reflecting a modest, compensation-related ownership position aligned with the company’s performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Shah Nigam H.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,013	$0.00	--

Holdings After Transaction: Common Stock — 4,013 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 4,013 units Transaction price per RSU: $0.0000 per unit Shares held after transaction: 4,013 shares +1 more

4 metrics

RSUs granted 4,013 units Grant to Nigam H. Shah on June 11, 2026

Transaction price per RSU $0.0000 per unit Equity compensation award, not an open-market purchase

Shares held after transaction 4,013 shares Direct ownership following RSU-related acquisition

RSU vesting date Earlier of June 11, 2027 or day before 2027 annual meeting Vesting schedule for Nigam H. Shah’s RSU grant

Key Terms

restricted stock units, RSUs, contingent right, annual meeting of stockholders

4 terms

restricted stock units financial

"the Reporting Person was granted restricted stock units ("RSUs") which fully vest"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"Each RSU represents a contingent right to receive one share of common stock"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

contingent right financial

"Each RSU represents a contingent right to receive one share of common stock"

annual meeting of stockholders financial

"the day before the Issuer's 2027 annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/12/2026 - 06:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Nigam H.

(Last)

(First)

(Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE

KENTUCKY

40222

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/11/2026		A⁽¹⁾		4,013	A	$0	4,013	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On June 11, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on the earlier of (i) June 11, 2027 and (ii) the day before the Issuer's 2027 annual meeting of stockholders. Each RSU represents a contingent right to receive one share of common stock upon settlement.

	/s/ Jennifer Phipps, as Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did BrightSpring (BTSG) report for Nigam H. Shah?

BrightSpring reported that director Nigam H. Shah received a grant of 4,013 restricted stock units on June 11, 2026. These RSUs are a compensation-related equity award, not an open-market stock purchase or sale, and convert into common shares upon settlement.

How many shares did Nigam H. Shah acquire in the latest BrightSpring (BTSG) Form 4?

Nigam H. Shah acquired 4,013 restricted stock units tied to BrightSpring common stock. Each RSU represents a contingent right to one share, so the award equates to 4,013 potential shares when the units vest and are settled under the plan’s terms.

What are the vesting terms of Nigam H. Shah’s RSU grant at BrightSpring (BTSG)?

The RSUs granted to Nigam H. Shah fully vest on the earlier of June 11, 2027 or the day before BrightSpring’s 2027 annual meeting of stockholders. Vesting must occur before the RSUs settle into shares of common stock for the director.

Did Nigam H. Shah pay cash for the 4,013 BrightSpring (BTSG) RSUs?

No cash was paid for the RSU grant, which is a standard form of equity compensation. The Form 4 shows a transaction price per share of $0.0000, indicating the award was granted as part of director compensation rather than purchased on the open market.